An Essential and Unique Virulence Molecule in Pathogenic Escherichia ColiTechnology #ua17-169
Questions about this technology? Ask a Technology Manager
- Gayatri Vedantam Associate professor, Animal and Comparative Biomedical Sciences
- Virinchipuram Viswanathan Associate Professor, SACBC
- Managed By
- Tod McCauley Sr. Licensing Manager (520) 626-7916
Title: An essential and unique virulence molecule in pathogenic Escherichia coli
Invention: The invention relates to a secreted protein that plays a critical role in mediating virulence of pathogenic E. coli. Utilizing a functionally equivalent mouse pathogen, in both in vitro and in vivo virulence studies, the investigators demonstrated that the premature death of intestinal epithelial cells could be prevented.
Background: There are no vaccine or antibiotic options to treat Enterohemorrhagic E. coli associated diarrhea. Pathogenic E. coli is also the leading cause of infantile diarrhea in developing countries. A secreted protein from E. coli prevents the premature death of intestinal epithelial cells by regulating the type III secretion system, which delivers virulence proteins from the pathogen to the host epithelial cells. There is an unmet need to develop a therapeutic option to prevent E. coli associated diarrheal disease.
• Pharmaceutical industry
• Novel drug target in a disease with high incidence
• Potential to develop future biomarkers and drug targets due to the better understanding of the disease process